Vir Biotechnology, Inc. (VIR) stock
VIRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3031% below fair value
$9.15−0.10 (-1.08%)
Close on Nov 18, 2026Market cap $1.55BP/E –Yield –
Vir Biotechnology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Vir Biotechnology's pe ratio was 6.6× on Apr 28, 2023, against 5.1× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Apr 28, 2023 | 6.6× | +3.6 |
| 2022 | Dec 30, 2022 | 3.0× | – |
See a number that looks wrong?